| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2024 | SENS Senseonics Holdings, Inc. | Goodnow Timothy T76 | President And CEO | Buy | 315,000 | $0.31 | $97,650.00 | +2.9% | +89.8% | +14.3% | |
| Dec 10, 2024 | SERA Sera Prognostics, Inc. | Lindgardt Zhenya75 | Chief Executive Officer | Sell | 26,224 | $7.41 | $194,319.84 | -3.2% | -49.6% | -58.6% | |
| Dec 10, 2024 | AHCO Adapthealth Corp. | Clemens Jason A | Chief Financial Officer | Sell | 35,000 | $9.35 | $327,250.00 | -7.7% | +9.6% | +7.9% | |
| Dec 10, 2024 | SSII Ss Innovations International, Inc. | Srivastava Sudhir | Chairman And CEO | Sell | 1,400,620 | $1.46 | $2,049,107.06 | -1.3% | - | - | |
| Dec 10, 2024 | BSX Boston Scientific Corp | Fitzgerald Joseph Michael51 | EVP &Group Pres, Cardiology | Sell | 20 | $89.97 | $1,799.44 | - | +4.4% | +2.8% | |
| Dec 9, 2024 | WRBY Warby Parker Inc. | Blumenthal Neil Harris66 | Co-chief Executive Officer | Sell | 50,000 | $23.65 | $1,182,500.00 | -80.4% | -13.7% | -1.2% | |
| Dec 9, 2024 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 5,000 | $71.75 | $358,750.50 | -9.6% | -3.3% | +17.5% | |
| Dec 9, 2024 | RMD Resmed Inc | Sandercock Brett62 | Chief Financial Officer | Sell | 1,000 | $244.23 | $244,230.00 | -1.1% | -3.3% | +0.7% | |
| Dec 9, 2024 | EW Edwards Lifesciences Corp | Ullem Scott B.65 | Cvp, Chief Financial Officer | Sell | 11,250 | $71.68 | $806,405.63 | -26.9% | -3.3% | +17.5% | |
| Dec 9, 2024 | RCEL Avita Medical, Inc. | Crowe Suzanne | Director | Buy | 486 | $13.15 | $6,390.90 | +1.3% | -39.3% | -74.2% | |
| Dec 9, 2024 | MXCT Maxcyte, Inc. | Johnston John Joseph75 | Director | Sell | 3,000 | $3.78 | $11,327.55 | -1.0% | -18.0% | -63.1% | |
| Dec 9, 2024 | BDX Becton Dickinson & Co | Goette Roland62 | EVP And President, Emea | Sell | 5,121 | $220.76 | $1,130,528.97 | -11.7% | +2.5% | -13.5% | |
| Dec 6, 2024 | SGHT Sight Sciences, Inc. | Raheja Manohar K.73 | EVP, Research &Development | Buy | 5,000 | $3.85 | $19,250.00 | +4.7% | -35.7% | +108.0% | |
| Dec 6, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 350 | $0.61 | $213.85 | - | +18.9% | +32.3% | |
| Dec 6, 2024 | EW Edwards Lifesciences Corp | Chopra Daveen59 | Cvp, Tmtt | Sell | 1,750 | $73.27 | $128,222.68 | -6.0% | +0.4% | +20.5% | |
| Dec 6, 2024 | DXR Daxor Corp | Feldschuh Michael Richard75 | Chief Executive Officer | Buy | 45,000 | $0.00 | - | +27.7% | -12.6% | +44.5% | |
| Dec 6, 2024 | SERA Sera Prognostics, Inc. | Mirza Mansoor Raza79 | Director | Sell | 93 | $7.12 | $662.16 | -1.4% | -43.5% | -58.1% | |
| Dec 6, 2024 | AORT Artivion, Inc. | Horton Amy48 | VP, Chief Accounting Officer | Sell | 4,329 | $29.66 | $128,398.14 | -3.1% | -16.7% | +50.3% | |
| Dec 6, 2024 | BDX Becton Dickinson & Co | Neal Shana Carol49 | EVP And Chief People Officer | Sell | 1,000 | $220.49 | $220,490.00 | -5.6% | +2.9% | -10.0% | |
| Dec 6, 2024 | EW Edwards Lifesciences Corp | Markowitz Wayne | Gm &SVP, Surgical | Sell | 583 | $73.27 | $42,716.41 | -5.8% | +0.4% | +20.5% | |
| Dec 6, 2024 | ICUI Icu Medical Inc/de | Woolson Daniel56 | VP, Gm-infusion Capital | Sell | 2,241 | $156.25 | $350,158.49 | -17.1% | -8.7% | -8.5% | |
| Dec 6, 2024 | DXR Daxor Corp | Feldschuh Jonathan Adam | Chief Scientific Officer | Buy | 32,000 | $0.00 | - | +818.8% | -12.6% | +44.5% | |
| Dec 5, 2024 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 6,293 | $0.62 | $3,902.92 | - | +29.0% | +32.7% | |
| Dec 5, 2024 | BDX Becton Dickinson & Co | Shan David48 | EVP And Chief Isc Officer | Sell | 1,500 | $220.25 | $330,375.00 | -19.3% | +1.3% | -10.9% | |
| Dec 5, 2024 | ELMD Electromed, Inc. | Summers Andrew79 | Director | Sell | 37,404 | $28.15 | $1,052,752.19 | -2.7% | -7.2% | -0.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.